Cohort of children with isolated nocturnal enuresis : a study of the safety of Minirinmelt in actual prescription

{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Child (6 to 12 years)","concept":{"vocab":"MeSH","vocabURI":"D002648"}},{"value":"Adolescent (13 to 18 years)","concept":{"vocab":"MeSH","vocabURI":"D000293"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Criteria for inclusion: -patient having an isolated nocturnal enuresis, defined by the number of wet nights per week, -patient aged 6 to 18 years, -patient in which the family doctor has decided to prescribe a treatment via desmopressin, or Minirin® tablets or Minirinmelt® lyophilisate. ","clusion_E":"patient who has already received prior treatment via desmopressin regardless of its form,-patient who has a treatment in progress via desmopressin,-patient participating in a therapeutic study."}